IEQ Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $22.3M | Buy |
120,035
+5,274
| +5% | +$979K | 0.14% | 113 |
|
2025
Q1 | $24M | Buy |
114,761
+38,156
| +50% | +$7.99M | 0.19% | 83 |
|
2024
Q4 | $13.6M | Sell |
76,605
-35,104
| -31% | -$6.24M | 0.13% | 99 |
|
2024
Q3 | $22.1M | Buy |
111,709
+7,153
| +7% | +$1.41M | 0.27% | 58 |
|
2024
Q2 | $17.9M | Sell |
104,556
-25,552
| -20% | -$4.38M | 0.24% | 60 |
|
2024
Q1 | $23.7M | Buy |
130,108
+40,467
| +45% | +$7.37M | 0.34% | 48 |
|
2023
Q4 | $13.9M | Buy |
89,641
+423
| +0.5% | +$65.6K | 0.23% | 65 |
|
2023
Q3 | $13.3M | Buy |
89,218
+8,860
| +11% | +$1.32M | 0.27% | 60 |
|
2023
Q2 | $10.8M | Sell |
80,358
-16,634
| -17% | -$2.24M | 0.22% | 74 |
|
2023
Q1 | $15.5M | Sell |
96,992
-3,192
| -3% | -$509K | 0.36% | 47 |
|
2022
Q4 | $16.2M | Buy |
100,184
+9,855
| +11% | +$1.59M | 0.45% | 40 |
|
2022
Q3 | $12.1M | Buy |
90,329
+10,415
| +13% | +$1.4M | 0.33% | 47 |
|
2022
Q2 | $12.2M | Buy |
79,914
+1,960
| +3% | +$300K | 0.37% | 49 |
|
2022
Q1 | $12.6M | Buy |
77,954
+10,278
| +15% | +$1.67M | 0.3% | 55 |
|
2021
Q4 | $9.16M | Buy |
67,676
+7,809
| +13% | +$1.06M | 0.21% | 66 |
|
2021
Q3 | $6.46M | Buy |
59,867
+3,022
| +5% | +$326K | 0.17% | 78 |
|
2021
Q2 | $6.4M | Buy |
56,845
+9,991
| +21% | +$1.13M | 0.19% | 74 |
|
2021
Q1 | $5.07M | Buy |
46,854
+2,245
| +5% | +$243K | 0.21% | 76 |
|
2020
Q4 | $4.78M | Buy |
44,609
+765
| +2% | +$82K | 0.21% | 80 |
|
2020
Q3 | $3.84M | Sell |
43,844
-4,480
| -9% | -$392K | 0.21% | 76 |
|
2020
Q2 | $4.74M | Buy |
48,324
+2,190
| +5% | +$215K | 0.31% | 58 |
|
2020
Q1 | $3.52M | Buy |
46,134
+41
| +0.1% | +$3.12K | 0.28% | 57 |
|
2019
Q4 | $4.08M | Buy |
+46,093
| New | +$4.08M | 0.36% | 42 |
|